Institute of Hypertension of the People's Hospital of Xinjiang Uygur Autonomous Region, Center of Diagnosis, Treatment and Research of Hypertension in Xinjiang, Xinjiang, China.
Clin Exp Hypertens. 2013;35(3):175-82. doi: 10.3109/10641963.2012.712175. Epub 2012 Aug 22.
The aim of this study was to examine the prevalence of primary aldosteronism (PA) in hypertensive patients with hyperglycemia. Two hundred and thirty-two hypertensive patients with hyperglycemia were screened for PA. Fifty-four subjects with an aldosterone/rennin activity ratio >20 ng/dL per ng/mL/hour underwent a saline loading test. Primary aldosteronism was present in 22.4% of patients with a plasma aldosterone concentration >5 ng/dL and 11.6% of those with plasma aldosterone concentrations >10 ng/dL. There were 14.0%-23.0% patients with PA in the diabetes mellitus group, 2.3%-23.3% in the impaired glucose tolerance group, and 9.1% in the impaired fasting glucose group. Primary aldosteronism is common in hypertensive individuals with hyperglycemia.
本研究旨在探讨伴有高血糖的高血压患者中原发性醛固酮增多症(PA)的患病率。对 232 例伴有高血糖的高血压患者进行了 PA 筛查。对醛固酮/肾素活性比值>20 ng/dL/ng/mL/hour 的 54 例患者进行了盐水负荷试验。血浆醛固酮浓度>5ng/dL 的患者中,22.4%存在原发性醛固酮增多症,血浆醛固酮浓度>10ng/dL 的患者中,11.6%存在原发性醛固酮增多症。糖尿病组中有 14.0%-23.0%的患者存在 PA,糖耐量受损组有 2.3%-23.3%,空腹血糖受损组有 9.1%。原发性醛固酮增多症在伴有高血糖的高血压患者中较为常见。